Charite 2019-nCoV BBQ-650 ValuPanel Reagents by LGC, Biosearch Technologies

Manufacturer LGC, Biosearch Technologies  |   Model: Multiple  |  Available Worldwide
Charité 2019-nCoV BBQ-650 ValuPanel™ Reagents are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19. For Research Use Only. Not for use in diagnostic procedures.


Charite 2019-nCoV BBQ-650 ValuPanel Reagents by LGC, Biosearch Technologies product image
Charite 2019-nCoV BBQ-650 ValuPanel Reagents
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

With a proven track record supporting public health crises and the expertise to rapidly scale high-quality oligonucleotide production to meet growing demand for testing reagents, LGC, Biosearch Technologies is prepared to support testing to help slow the spread of COVID-19.

Key features

  • Flexibility: Probes and primers are delivered in individual tubes, available in different sizes to support anywhere from 1,000 to 100,000 reactions to meet the requirements of various protocols and offer the ability to scale
  • Original source, reliable supply: Both BHQ™ and BlackBerry™ (BBQ-650) quenchers referenced in the Charité and US CDC protocols are Biosearch Technologies’ proprietary technology.  Berry & Associates, Inventor of BBQ-650 technology is now part of the Biosearch Technologies brand.
  • Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production. 

Product info

This panel consists of FAM-BBQ-650 probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:

  • RdRP - Confirmatory assay
    • Pan Sarbeco-Probe to detect 2019-nCoV, SARS-CoV and bat-SARS-related CoVs
    • Probe specific for 2019-nCoV, will not detect SARS-CoV
  • E Sarbeco - First line screening assay

Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BlackBerry (BBQ-650) dyes, and are HPLC purified. Berry & Associates, the inventor of BBQ-650 technology, is now part of the Biosearch Technologies brand.